Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:57:04 EST Sat 13 Dec 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:PPCB - PROPANC BIOPHARMA INC - https://www.propanc.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PPCB - Q5.00.7545·3.534.40.7884-0.0183-2.318.911820.7998  0.7998  0.76159.36  0.7319:48:29Dec 0415 min RT 2¢

Recent Trades - Last 10 of 82
Time ETExPriceChangeVolume
19:48:29Q0.7562-0.05051,019
18:23:52Q0.7625-0.044250
17:27:42Q0.7625-0.0442300
17:22:36Q0.7625-0.04429
17:17:08Q0.77-0.0367913
16:58:06Q0.7712-0.035510
16:30:59Q0.7712-0.03551,000
16:10:04Q0.7884-0.01831
16:04:08Q0.7884-0.01831
16:00:01Q0.7884-0.018313

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-12-04 08:45U:PPCBNews ReleasePropanc Biopharma Investigates "Mesenchymal Drift" to Reverse Chronic Diseases Defined by Altos Labs
2025-12-01 08:45U:PPCBNews ReleasePropanc Biopharma Requests Foreign Filing License from Spain for Methods of Treating Resistant Cancer and Fibrosis
2025-11-17 08:45U:PPCBNews ReleasePropanc Biopharma Provides Corporate Update and Reports First Quarter 2025/26 Results
2025-11-10 08:45U:PPCBNews ReleasePropanc Biopharma, Inc. Secures up to $100 Million Private Placement to Support Digital Asset Acquisition Strategy & Accelerate Company's R&D Pipeline
2025-11-04 07:00U:PPCBNews ReleasePropanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV)
2025-10-15 17:45U:PPCBNews ReleaseCORRECTION: Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital
2025-10-15 08:45U:PPCBNews ReleasePropanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital
2025-10-07 08:45U:PPCBNews ReleasePropanc Reports End of Fiscal Year Highlights and Outlines Therapeutic Development & $100M+ Digital Asset Treasury Strategy
2025-09-17 08:45U:PPCBNews ReleasePropanc Biopharma Receives Certificate of Grant for "Proenzyme Composition" Patent from US Patent & Trademark Office
2025-09-02 09:00U:PPCBNews ReleasePropanc Biopharma Announces Plan to Acquire $100 Million of Ethereum
2025-08-25 07:30U:PPCBNews ReleasePropanc Biopharma Provides Shareholder Update
2025-08-19 08:30U:PPCBNews ReleasePropanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ
2025-08-14 23:00U:PPCBNews ReleasePropanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering